)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Jade Biosciences
Jade Biosciences (JBIO) investor relations material
Jade Biosciences Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary7 May, 2026
Company overview and business model
Clinical-stage biopharmaceutical company focused on novel biologic therapies for autoimmune diseases, aiming to improve dosing, convenience, safety, and clinical activity compared to current treatments.
Lead product candidate JADE101 targets APRIL for IgA nephropathy; pipeline includes JADE201 (BAFF-R) and JADE301 (undisclosed pathway).
Formed through a merger between Aerovate Therapeutics and Pre-Merger Jade, with significant private financing and subsequent rebranding.
Financial performance and metrics
Raised $334.2 million in pre-merger financing, including $95 million from convertible notes and $8.3 million in accrued interest.
October 2025 PIPE raised approximately $135 million at $9.14 per share; December 2025 PIPE raised $45 million at $14.00 per share.
As of March 31, 2026, 49,345,967 shares of common stock outstanding, with additional shares reserved for options, warrants, and equity plans.
Use of proceeds and capital allocation
No proceeds from resale of shares by selling stockholders; nominal proceeds may be received from warrant exercises, intended for general corporate purposes.
No proceeds from conversion of Series A Preferred Stock.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jade Biosciences
- Advancing high-affinity autoimmune therapies with strong cash position and key trials in 2026–2027.JBIO
Company presentation8 May 2026 - Biotech seeks up to $600M, including $200M at-the-market, to fund autoimmune pipeline and operations.JBIORegistration filing8 May 2026
- Net loss rose to $40.4M in Q1 2026 as pipeline advanced; cash runway extends into H1 2028.JBIOQ1 20268 May 2026
- Key votes include director elections, auditor ratification, and a jury trial waiver amendment.JBIOProxy filing28 Apr 2026
- Board recommends electing directors, ratifying auditor, and approving a jury trial waiver amendment.JBIOProxy filing28 Apr 2026
- Board seeks approval for director elections, auditor ratification, and a jury trial waiver amendment.JBIOProxy filing17 Apr 2026
- Advancing high-affinity anti-APRIL therapy for IgAN with extended dosing and rapid clinical progress.JBIOLeerink Global Healthcare Conference 202611 Mar 2026
- Pipeline targets best-in-class autoimmune therapies with strong cash runway and major market focus.JBIOCorporate presentation6 Mar 2026
- Strong cash position and advancing pipeline set stage for key clinical milestones in 2026–2027.JBIOQ4 20256 Mar 2026
Next Jade Biosciences earnings date
Q2 20267 Aug, 2026
Jade Biosciences
Next Jade Biosciences earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage